Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

Spotify and Warner Music Group (NASDAQ: WMG) today announced a new, multi-year agreement, which covers both Recorded Music ...